NCT05416138View on ClinicalTrials.gov

Theta Phase-specific TMS to Modulate Prefrontal Activity

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Approach/Avoidance Behavior
Interventions
DEVICE

Transcranial magnetic stimulation (TMS)

TMS will be performed at either peaks or troughs of ongoing prefrontal theta oscillations (3-7 Hz) concurrently with the cognitive test at the beginning of every test trial. Theta oscillations will be monitored in real-time at the left dorsolateral prefrontal cortex using electroencephalography (EEG).

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Minnesota

OTHER